医学
癌症
人口
癌症筛查
宫颈癌
结直肠癌
乳腺癌
中国
家庭医学
环境卫生
内科学
政治学
法学
作者
Changfa Xia,Partha Basu,Barnett S. Kramer,Li He,Chunfeng Qu,Xue Qin Yu,Karen Canfell,You‐Lin Qiao,Bruce K. Armstrong,Wanqing Chen
标识
DOI:10.1016/s2468-2667(23)00186-x
摘要
Cancer screening has the potential to decrease mortality from several common cancer types. The first cancer screening programme in China was initiated in 1958 and the Cancer High Incidence Fields established in the 1970s have provided an extensive source of information for national cancer screening programmes. From 2012 onwards, four ongoing national cancer screening programmes have targeted eight cancer types: cervical, breast, colorectal, lung, oesophageal, stomach, liver, and nasopharyngeal cancers. By synthesising evidence from pilot screening programmes and population-based studies for various screening tests, China has developed a series of cancer screening guidelines. Nevertheless, challenges remain for the implementation of a fully successful population-based programme. The aim of this Review is to highlight the key milestones and the current status of cancer screening in China, describe what has been achieved to date, and identify the barriers in transitioning from evidence to implementation. We also make a set of implementation recommendations on the basis of the Chinese experience, which might be useful in the establishment of cancer screening programmes in other countries.
科研通智能强力驱动
Strongly Powered by AbleSci AI